InspireMD, Inc.
Develops an FDA-approved carotid stent system for stroke prevention in high-risk patients.
NSPR | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 6303 WATERFORD DISTRICT DRIVE, 33126 MIAMI
- Website:
- https://www.inspiremd.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
InspireMD, Inc. is a commercial-stage medical device company dedicated to stroke prevention through the development and commercialization of its proprietary MicroNet™ stent platform technology. The company's flagship product, the CGuard® Prime Carotid Stent System, is a novel dual-layer device featuring a conformable stent overwrapped with a non-metallic mesh. This design aims to improve carotid luminal diameter while trapping plaque against the vessel wall to minimize the risk of embolization during and after carotid artery stenting procedures. The system is indicated for patients with significant carotid artery stenosis at high risk for surgical intervention. Supported by clinical data demonstrating low rates of major adverse events, the CGuard Prime system has received FDA approval.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all InspireMD, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for InspireMD, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for InspireMD, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
